The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of hypoxia measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and the malignant progression of gliomas.
Man Hu
No relevant relationships to disclose
Yufang Zhu
No relevant relationships to disclose
Bingjie Fan
No relevant relationships to disclose
Wenwu Li
No relevant relationships to disclose
Dianbin Mu
No relevant relationships to disclose
Shuqiang Zhao
No relevant relationships to disclose
Dexian Zhang
No relevant relationships to disclose
Xiaorong Sun
No relevant relationships to disclose
Zheng Fu
No relevant relationships to disclose
Jinsong Zheng
No relevant relationships to disclose
Li Ma
No relevant relationships to disclose
Jujie Sun
No relevant relationships to disclose
Li Kong
No relevant relationships to disclose
Jinming Yu
No relevant relationships to disclose